As of 2025-10-27, the EV/EBITDA ratio of Ocular Therapeutix Inc (OCUL) is -10.81. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OCUL's latest enterprise value is 2,422.44 mil USD. OCUL's TTM EBITDA according to its financial statements is -224.19 mil USD. Dividing these 2 quantities gives us the above OCUL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.1x - 8.9x | 6.2x |
| Forward P/E multiples | 7.8x - 12.8x | 9.9x |
| Fair Price | (8.25) - (9.46) | (8.59) |
| Upside | -171.8% - -182.4% | -174.7% |
| Date | EV/EBITDA |